Extension Study Evaluating The Safety And Tolerability of AMX0035

NCT05619783 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: AMX0035

Sponsor

Amylyx Pharmaceuticals Inc.